Crossmark

The relationship between lung fibrosis, the epidermal growth factor receptor, and disease outcomes in COVID-19 pneumonia: a postmortem evaluation

Published Online: 2022-08-20

Authors

Dülger, Seyhan Us https://orcid.org/0000-0003-0073-3506
Mutlu, Nazmi

Ceylan, İlkay

Özhan, Erhan
Clinical Trials ^BETA

Clinical trials referenced in this document:

nct05290441 at ClinicalTrials.gov

Documents that mention this clinical trial

The relationship between lung fibrosis, the epidermal growth factor receptor, and disease outcomes in COVID-19 pneumonia: a postmortem evaluation
https://doi.org/10.1007/s10238-022-00872-7
License Information

Text and Data Mining valid from 2022-08-20

Version of Record valid from 2022-08-20
More Information

Article History

Received: 26 May 2022

Accepted: 3 August 2022

First Online: 20 August 2022

Declarations

:

: The authors declare that they have no conflicts of interest.

Free to read: This content has been made available to all.

Document is current